Learn your clients' addiction risk and best treatment options.
McRISC© is a 10-minute online SUD assessment, prevention and treatment referral guide, accessible 24/7 to all populations. It measures a person’s current and lifelong risk of becoming addicted and the likelihood of remission for those already experiencing SUD, so that providers can prescribe accordingly. McRISC© aims to reframe SUD as a chronic illness that must be treated just as we treat diabetes and heart disease.
Your anonymous participation helps us externally validate McRISC©'s solid construct validity for the best prevention, and rehab options.
The misinformed use of opiates for chronic pain, plus a generation of docs trained to remove all pain, created the current opioid crisis. How do we treat either of these chronic illnesses without assessing life-long risk, severity and appropriate management?
How do we know who will best benefit from which medicine, or whether we're simply extending a more functional brain damaging dependence, unless we include a chronic illness-driven, longer view, assessment and treatment strategy?
How do we know who would most likely benefit from combined behavioral and medication-assisted treatment for just a year or two and who may need some form of ongoing treatment for the rest of their lives to achieve a sustained recovery?
We assess it.
McRISC© is a new online, 10-minute self-report assessment tool that evaluates the risk of developing a chronic substance addiction. It assesses, sorts, and quantifies evidence-based risk factors like genetics, early and prolonged exposure, brain illnesses, life stressors, and substance-related events, through a longer illness lens. An embedded, acute SUD assessment tool for prevention, treatment planning and rehab, complements the tool's chronic illness focus.
McRISC© assessment offers advanced guidance to both opiate prescribers and addiction recovery providers. Pain management prescibers can better identify those more likely to have, or develop, a substance dependency. Providers can now select which medication-assisted treatment (MAT) and duration is best suited for a given person. A built-in Ready Meter (RM) helps monitor current readiness to be in rehab and longer lasting remission, for more cost-effective substance abuse treatment timing.
Combined with other key risk factors, McRISC© incorporates the latest research confirming the impact of early and prolonged substance exposure on the developing brain. A higher Remission Index (RI) coincides with a brain likely to more fully recover with rehab, while a lower RI suggests increased addiction risk for prolonged brain impairment. McRISC© saves lives by risk-stratifying who's brain is more chronically held hostage as a key reference for best prevention or treatment.
For comments or questions, please contact us
or the Institutional Review Board Office at email@example.com or by phone at 855-226-4472.
MCRISC©: A LONGER LIFE-SAVING VIEW OF RECOVERY